Boxer Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Other funds holding XENE
Boxer Capital Management's XENE Position: Q2 2025 in Review
Boxer Capital Management sold out of Xenon Pharmaceuticals (XENE) in Q2 2025, closing a stake of 600,000 shares — an estimated $20.1M sold.
Boxer Capital Management first reported a position in XENE in Q3 2018 and held it in 20 quarters. The position peaked at $27.6M in Q4 2023. 207 funds tracked by Wall St. Rank hold XENE as of Q2 2025.
- Boxer Capital Management reported no remaining Xenon Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
- Boxer Capital Management sold 600,000 Xenon Pharmaceuticals shares in Q2 2025, an estimated $20.1M.
- Boxer Capital Management first reported a position in Xenon Pharmaceuticals in Q3 2018 and held it in 20 quarters.
- Boxer Capital Management's Xenon Pharmaceuticals position peaked at $27.6M in Q4 2023.
- 207 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2025.
Based on Boxer Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.